Changeflow GovPing Healthcare FDA Class II Device Recall: GEM Premier 5000
Urgent Enforcement Removed Final

FDA Class II Device Recall: GEM Premier 5000

Favicon for changeflow.com FDA: Device Recalls Class II
Filed March 18th, 2026
Detected March 29th, 2026
Email

Summary

The FDA has initiated a Class II device recall for Instrumentation Laboratory's GEM Premier 5000, Part No. 00055415008, due to Process Control Solution Not Detected (PCSND) errors. The recall affects worldwide distribution, including the US.

What changed

The FDA has classified a recall of the GEM Premier 5000 device (Part No. 00055415008) as Class II, indicating that use of or exposure to a defective product may cause adverse health consequences that are temporary or medically reversible. The issue stems from confirmed customer complaints of Process Control Solution Not Detected (PCSND) errors during the warm-up phase of the GEM PAK cartridges, which can lead to GEM PAK ejection.

This recall impacts worldwide distribution, including the United States and several other countries. Manufacturers and healthcare providers utilizing this device should be aware of this recall and consult Instrumentation Laboratory's specific instructions for managing the affected product. While the document does not specify a compliance deadline, the ongoing nature of the recall implies immediate attention is required for affected units and inventory.

What to do next

  1. Review Instrumentation Laboratory's recall instructions for GEM Premier 5000
  2. Identify and manage affected GEM PAK cartridges and devices
  3. Report any adverse events related to this issue to the FDA

Source document (simplified)

Instrumentation Laboratory

Device Recalls (Class II)

← All Device Recalls (Class II) Class II Z-1534-2026 · 20260318 · Ongoing

Product

GEM Premier 5000; Part No. 00055415008.

Reason for Recall

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of ...

Distribution

Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada,...

Source: openFDA Enforcement API

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Filed
March 18th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Z-1534-2026

Who this affects

Applies to
Manufacturers Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Device Recalls
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Compliance
Topics
Product Safety Recall Management

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when FDA: Device Recalls Class II publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.